Eurofins Scientific SE/ FR0014000MR3 /
11/12/2024 5:39:03 PM | Chg. -0.750 | Volume | Bid7:30:01 AM | Ask7:30:45 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
45.400EUR | -1.63% | 450,293 Turnover: 20.5 mill. |
45.500Bid Size: 2,000 | 44.000Ask Size: 100 | 8.76 bill.EUR | 1.10% | 15.34 |
Assets
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 427.5000 | 506.8000 | 686 | 1,018 | 1,593.5000 | ||||||
Intangible Assets | 351.5000 | 383.2000 | 735.1000 | 946.9000 | 918.2000 | ||||||
Long-Term Investments | 32.1000 | 34.2000 | 43.9000 | 67.6000 | 49.2000 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 37.5000 | 39.5000 | 51.8000 | 66.4000 | 79.3000 | ||||||
Accounts Receivable | 443.2000 | 524.5000 | 705.7000 | 864.9000 | 1,001.2000 | ||||||
Cash and Cash Equivalents | 793.8000 | 826.1000 | 820.4000 | 506.2000 | 297 | ||||||
Current Assets | 1,424.3000 | 1,579.4000 | 1,826.6000 | 1,705.4000 | 1,604.1000 | ||||||
Total Assets | 3,699.8000 | 4,129.4000 | 5,832.3000 | 7,205.4000 | 7,823.1000 |
Liabilities
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 197 | 230.1000 | 301.9000 | 373 | 409.8000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 265.2000 | 101.7000 | 618.7000 | 457.1000 | 504.8000 | ||||||
Provisions | 94.1000 | 83.9000 | 126.4000 | 138.6000 | 124.5000 | ||||||
Liabilities | 2,619.5000 | 2,372.7000 | 3,350.3000 | 4,483.3000 | 4,925 | ||||||
Share Capital | 1.5390 | 1.6930 | 1.7640 | 1.7750 | 1.8000 | ||||||
Total Equity | 957.3000 | 1,627.5000 | 2,443.2000 | 2,669.2000 | 2,838.6000 | ||||||
Minority Interests | 123 | 129.2000 | 38.8000 | 53 | 59.5000 | ||||||
Total liabilities equity | 3,699.8000 | 4,129.4000 | 5,832.3000 | 7,205.4000 | 7,823.1000 |
Income Statement
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,950.1000 | 2,536.6000 | 2,971.4000 | 3,781.1000 | 4,562.8000 | ||||||
Depreciation (total) | 111 | 141.7000 | 175.7000 | 223.7000 | 395.9000 | ||||||
Operating Result | 198.1000 | 281.9000 | 296.8000 | 344 | 366.6000 | ||||||
Interest Income | -66.1000 | -39.8000 | -47.1000 | -54.5000 | -95.7000 | ||||||
Income Before Taxes | 132.4000 | 242.6000 | 250.1000 | 289.8000 | 271.5000 | ||||||
Income Taxes | 42.2000 | 65.1000 | 31.3000 | 66.3000 | 76.3000 | ||||||
Minority Interests Profit | -2.8000 | -3.5000 | -2.1000 | .4000 | 0.0000 | ||||||
Net Income | 87.3000 | 174 | 216.8000 | 224 | 195.2000 |
Per Share
Cash Flow
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 291.1000 | 371.8000 | 405.1000 | 543.9000 | 677.9000 | ||||||
Cash Flow from Investing Activities | -863.5000 | -391.8000 | -1,747.1000 | -1,557.4000 | -540.2000 | ||||||
Cash Flow from Financing | 1,142.9000 | 49.9000 | 1,343.3000 | 691.1000 | -342.2000 | ||||||
Decrease / Increase in Cash | 576 | 34.6000 | -9.6000 | -321 | -200.5000 | ||||||
Employees | 18,382 | 23,401 | 28,259 | 36,518 | 43,320 |